Eur Rev Med Pharmacol Sci 2021; 25 (5): 2168-2169
DOI: 10.26355/eurrev_202103_25206

Commentary: Could cancer stem cells be considered as alpha and omega in cancer progression?

L. Domenici

Division of Obstetrics and Gynecology II, Department of Experimental and Clinical Medicine, University of Pisa, Pisa, Italy. lavinia.domenici@gmail.com

Free PDF Download

To cite this article

L. Domenici
Commentary: Could cancer stem cells be considered as alpha and omega in cancer progression?

Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 5
Pages: 2168-2169
DOI: 10.26355/eurrev_202103_25206

Keywords Related articles:

  1. CD44+/CD24+ cervical cancer cells resist radiotherapy and exhibit properties of cancer stem cells
  2. Expression of embryonic liver fodrin (ELF) and stem cell markers in CD13 liver cancer stem cells
  3. Omega-3 polyunsaturated fatty acid inhibits the malignant progression of hepatocarcinoma by inhibiting the Wnt/β-catenin pathway
  4. Comment on: Omega-3 polyunsaturated fatty acid inhibits the malignant progression of hepatocarcinoma by inhibiting the Wnt/β-catenin pathway
  5. Should prostate cancer be considered as a differential diagnosis in patients with osteolytic bone lesions?